相似文献
1
Karyotype evolution on fluorescent in situ hybridization analysis is associated with short survival in patients with chronic lymphocytic leukemia and is related to CD49d expression.
J Clin Oncol. 2008 May 10;26(14):e5-6. doi: 10.1200/JCO.2008.16.7874.
2
Relevance of CD49d protein expression as overall survival and progressive disease prognosticator in chronic lymphocytic leukemia.
Blood. 2008 Jan 15;111(2):865-73. doi: 10.1182/blood-2007-05-092486. Epub 2007 Oct 24.
3
[The correlation of CD49d expression pattern with molecular genetics and hotspot gene mutants in patients with chronic lymphocytic leukemia].
Zhonghua Xue Ye Xue Za Zhi. 2022 Jun 14;43(6):463-468. doi: 10.3760/cma.j.issn.0253-2727.2022.06.004.
4
CD49d expression is an independent predictor of overall survival in patients with chronic lymphocytic leukaemia: a prognostic parameter with therapeutic potential.
Br J Haematol. 2008 Mar;140(5):537-46. doi: 10.1111/j.1365-2141.2007.06965.x.
5
CD49d is the strongest flow cytometry-based predictor of overall survival in chronic lymphocytic leukemia.
J Clin Oncol. 2014 Mar 20;32(9):897-904. doi: 10.1200/JCO.2013.50.8515. Epub 2014 Feb 10.
6
Low CD49d expression and long telomere identify a chronic lymphocytic leukemia subset with highly favourable outcome.
Am J Hematol. 2010 Aug;85(8):619-22. doi: 10.1002/ajh.21756.
7
CD49d associates with nodal presentation and subsequent development of lymphadenopathy in patients with chronic lymphocytic leukaemia.
Br J Haematol. 2017 Jul;178(1):99-105. doi: 10.1111/bjh.14647. Epub 2017 Apr 7.
8
CD49d is an independent prognostic marker that is associated with CXCR4 expression in CLL.
Leuk Res. 2011 Jun;35(6):750-6. doi: 10.1016/j.leukres.2010.10.022. Epub 2010 Nov 18.
9
CD49d shows superior performance characteristics for flow cytometric prognostic testing in chronic lymphocytic leukemia/small lymphocytic lymphoma.
Cytometry B Clin Cytom. 2018 Jan;94(1):129-135. doi: 10.1002/cyto.b.21384. Epub 2016 Jun 27.
10
High CD49d protein and mRNA expression predicts poor outcome in chronic lymphocytic leukemia.
Clin Immunol. 2009 Jun;131(3):472-80. doi: 10.1016/j.clim.2009.02.004. Epub 2009 Mar 24.
引用本文的文献
1
Chronic Lymphocytic Leukemia.
Cold Spring Harb Perspect Med. 2021 Feb 1;11(2):a035220. doi: 10.1101/cshperspect.a035220.
2
CLL intraclonal fractions exhibit established and recently acquired patterns of DNA methylation.
Blood Adv. 2020 Mar 10;4(5):893-905. doi: 10.1182/bloodadvances.2019000817.
3
Morphological, immunophenotypic, and genetic features of chronic lymphocytic leukemia with trisomy 12: a comprehensive review.
Haematologica. 2018 Jun;103(6):931-938. doi: 10.3324/haematol.2017.186684. Epub 2018 May 10.
4
A Quantitative Analysis of Subclonal and Clonal Gene Mutations before and after Therapy in Chronic Lymphocytic Leukemia.
Clin Cancer Res. 2016 Sep 1;22(17):4525-35. doi: 10.1158/1078-0432.CCR-15-3103. Epub 2016 Apr 8.
5
Clonality and evolutionary history of rhabdomyosarcoma.
PLoS Genet. 2015 Mar 13;11(3):e1005075. doi: 10.1371/journal.pgen.1005075. eCollection 2015 Mar.
6
Evolving understanding of the CLL genome.
Semin Hematol. 2014 Jul;51(3):177-87. doi: 10.1053/j.seminhematol.2014.05.004. Epub 2014 May 15.
7
CD49d is the strongest flow cytometry-based predictor of overall survival in chronic lymphocytic leukemia.
J Clin Oncol. 2014 Mar 20;32(9):897-904. doi: 10.1200/JCO.2013.50.8515. Epub 2014 Feb 10.
8
Characterization of a new chronic lymphocytic leukemia cell line for mechanistic in vitro and in vivo studies relevant to disease.
PLoS One. 2013 Oct 9;8(10):e76607. doi: 10.1371/journal.pone.0076607. eCollection 2013.
9
Chronic lymphocytic leukemia: molecular heterogeneity revealed by high-throughput genomics.
Genome Med. 2013 May 29;5(5):47. doi: 10.1186/gm451. eCollection 2013.
10
Clonal evolution, genomic drivers, and effects of therapy in chronic lymphocytic leukemia.
Clin Cancer Res. 2013 Jun 1;19(11):2893-904. doi: 10.1158/1078-0432.CCR-13-0138. Epub 2013 Apr 25.
本文引用的文献
1
CD49d expression is an independent predictor of overall survival in patients with chronic lymphocytic leukaemia: a prognostic parameter with therapeutic potential.
Br J Haematol. 2008 Mar;140(5):537-46. doi: 10.1111/j.1365-2141.2007.06965.x.
2
Relevance of CD49d protein expression as overall survival and progressive disease prognosticator in chronic lymphocytic leukemia.
Blood. 2008 Jan 15;111(2):865-73. doi: 10.1182/blood-2007-05-092486. Epub 2007 Oct 24.
3
Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial.
Lancet. 2007 Jul 21;370(9583):230-239. doi: 10.1016/S0140-6736(07)61125-8.
4
Prospective evaluation of clonal evolution during long-term follow-up of patients with untreated early-stage chronic lymphocytic leukemia.
J Clin Oncol. 2006 Oct 1;24(28):4634-41. doi: 10.1200/JCO.2006.06.9492.
5
Genomic aberrations and survival in chronic lymphocytic leukemia.
N Engl J Med. 2000 Dec 28;343(26):1910-6. doi: 10.1056/NEJM200012283432602.
Zotero 插件